Frazier Life Sciences

Palo Alto, Californiafrazierls.com

Overview

Frazier Life Sciences is a healthcare investment firm that invests globally in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals.

Year Founded

2005

AUM

$3.9B

Portfolio Companies

Website

frazierls.com

Investments

Frazier Life Sciences investments
Company	Date	Stage	Lead
Crystalys Therapeutics	Jul 2026	Series B	Lead
RQ Biotechnology Limited	Jun 2026	Series A	Lead
cAMPfield Therapeutics	Jun 2026	Series A	Lead
cAMPfield Therapeutics	May 2026	Series A	Co-investor
Sidewinder Therapeutics	Apr 2026	Series B	Lead

View all investments

Key People

Patrick Heron

Managing Partner

Daniel Estes

General Partner

Jamie B.

General Partner And Portfolio Manager

Adam Simpson

Venture Partner

Aditya Kohli

Venture Partner

Mitchell Gold

Venture Partner

Stanford Peng

Venture Partner

Tao Fu

Venture Partner

Anna H. Chen

Partner

Jennifer Martin

Chief Financial Officer and Partner

Ailsa Dalgliesh

Head Of Investor Relations

Chris Aakre

Principal Of Company Creation

Lauren Mifflin

Principal, Company Creation

Gordon Empey

Partner & General Counsel

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium

SeedSeries ASeries BGrowth

Unlock portfolio analytics

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium

2021

2022

2023

2024

2025

2026

Unlock portfolio analytics

FAQ

Firmographic Details

HeadquartersPalo Alto, California

Year Founded2005

AUM$3.9B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?